Cardiovascular News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 14 articles
ISPOR 2026: Top Cardiology Innovations & Research Highlights
ISPOR 2026: Cardiology Advances in Cost-Effectiveness Research
Edwards Lifesciences RESILIA Tissue Shows 10-Year Durability in Pivotal Aortic Valve Trial
Novo Nordisk's Oral Ozempic Becomes First FDA-Approved Pill GLP-1 for Type 2 Diabetes with Cardiovascular Protection
AOP Health US Treats First Patient with Rapiblyk (Landiolol) in United States at Valley Hospital
Berlin Heals Reports Positive First-in-Human Results for Less Invasive Heart Failure Device in CMIC-III Study
Nectero Therapeutics Reports Positive Two-Year Safety Data for EAST System in Abdominal Aortic Aneurysm Trial
Efemoral Medical's Bioresorbable Scaffold Achieves 97% Patency Rate in Peripheral Artery Disease Trial
InVera Medical Reports 90% Vein Closure Success Rate in 12-Month Chronic Venous Disease Trial
Lilly's Foundayo Shows 57% Mortality Reduction in Landmark ACHIEVE-4 Diabetes Trial
Medera's AAV-SERCA2a Gene Therapy Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Cardiomyopathy
Vasa Therapeutics Partners with Eli Lilly's TuneLab AI Platform for CAMKII Inhibitor Development